Natural strain variation and antibody neutralization of dengue serotype 3 viruses

PLoS Pathogens

Volumn 6, Issue 3, 2010, Pages

  Wahala, Wahala M P B ^a   Donaldson, Eric F ^b   De Alwis, Ruklanthi ^a   Accavitti Loper, Mary Ann ^c   Baric, Ralph S ^a,b   De Silva, Aravinda M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PROTEIN EDIII; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; EPITOPE; MONOCLONAL ANTIBODY; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONTROLLED STUDY; DENGUE VIRUS; GENETIC CONSERVATION; GENOTYPE; HUMAN; HUMAN CELL; NONHUMAN; PHYLOGENY; PROTEIN BINDING; PROTEIN DOMAIN; SEROTYPE; STRAIN DIFFERENCE; VIRUS NEUTRALIZATION; AEDES; ANIMAL; CELL STRAIN U937; CERCOPITHECUS; CLASSIFICATION; CYTOLOGY; DENGUE; EPITOPE MAPPING; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; SERODIAGNOSIS; SITE DIRECTED MUTAGENESIS; VERO CELL; VIROLOGY;

DENGUE VIRUS GROUP;

AEDES; ANIMALS; ANTIBODIES, MONOCLONAL; CERCOPITHECUS AETHIOPS; DENGUE; DENGUE VIRUS; EPITOPE MAPPING; EPITOPES; GENOTYPE; HUMANS; MICE; MUTAGENESIS, SITE-DIRECTED; NEUTRALIZATION TESTS; PROTEIN BINDING; U937 CELLS; VERO CELLS; VIRAL PROTEINS;

EID: 77950448257     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000821     Document Type: Article

References (38)

1. Halstead SB (2007) Dengue. Lancet 370: 1644-1652.
2. Sabin AB (1952) Research on dengue during World War II. Am J Trop Med Hyg 1: 30-50.
3. Imrie A, Meeks J, Gurary A, Sukhbaatar M, Truong TT, et al. (2007) Antibody to Dengue 1 Detected More Than 60 Years after Infection. Viral Immunology 20: 672-675.
4. Rico-Hesse R (2003) Microevolution and virulence of dengue viruses. Adv Virus Res 59: 315-341.
5. Blaney JE, Jr., Matro JM, Murphy BR, Whitehead SS (2005) Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J Virol 79: 5516-5528.
6. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, et al. (2004) Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189: 990-1000. (Pubitemid 38373090)
7. Zulueta A, Martin J, Hermida L, Alvarez M, Valdes I, et al. (2006) Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice. Virus Res 121: 65-73. (Pubitemid 44040901)
8. Li L, Barrett AD, Beasley DW (2005) Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains. Virology 335: 99-105. (Pubitemid 40489055)
9. Sanchez MD, Pierson TC, McAllister D, Hanna SL, Puffer BA, et al. (2005) Characterization of neutralizing antibodies to West Nile virus. Virology 336: 70-82. (Pubitemid 40603672)
10. Roehrig JT (2003) Antigenic structure of flavivirus proteins. Adv Virus Res 59: 141-175.
11. Modis Y, Ogata S, Clements D, Harrison SC (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100: 6986-6991. (Pubitemid 36706380)
12. Modis Y, Ogata S, Clements D, Harrison SC (2005) Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79: 1223-1231. (Pubitemid 40053904)
13. Nybakken GE, Nelson CA, Chen BR, Diamond MS, Fremont DH (2006) Crystal structure of the West Nile virus envelope glycoprotein. J Virol 80: 11467-11474.
14. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375: 291-298.
15. Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, et al. (2007) Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes. J Virol 81: 12816-12826. (Pubitemid 350156919)
16. Crill WD, Chang G-JJ (2004) Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes. J Virol 78: 13975-13986.
17. Gromowski GD, Barrett ADT (2007) Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 366: 349-360.
18. Pierson TC, Fremont DH, Kuhn RJ, Diamond MS (2008) Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 4: 229-238.
19. Pierson TC, Diamond MS (2008) Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev Mol Med 10: e12.
20. Hermida L, Bernardo L, Martin J, Alvarez M, Prado I, et al. (2006) A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates. Vaccine 24: 3165-3171.
21. Etemad B, Batra G, Raut R, Dahiya S, Khanam S, et al. (2008) An Envelope Domain III-based Chimeric Antigen Produced in Pichia pastoris Elicits Neutralizing Antibodies Against All Four Dengue Virus Serotypes. Am J Trop Med Hyg 79: 353-363.
22. Kraus AA, Messer W, Haymore LB, de Silva AM (2007) Comparison of Plaque-and Flow Cytometry- Based Methods for Measuring Dengue Virus Neutralization. J Clin Microbiol 45: 3777-3780. (Pubitemid 350156883)
23. Serafin IL, Aaskov JG (2001) Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies. Archives of Virology 146: 2469-2479. (Pubitemid 34682400)
24. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, et al. (2003) Multiple sequence alignment with the Clustal series of programs. Nucl Acids Res 31: 3497-3500. (Pubitemid 37442184)
25. Halstead SB (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60: 421-467.
26. Lanciotti RS, Lewis JG, Gubler DJ, Trent DW (1994) Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol 75: 65-75.
27. Gromowski GD, Barrett ND, Barrett AD (2008) Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J Virol 82: 8828-8837.
28. Rajamanonmani R, Nkenfou C, Clancy P, Yau YH, Shochat SG, et al. (2009) On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes. J Gen Virol 90: 799-809.
29. Nybakken GE, Oliphant T, Johnson S, Burke S, Diamond MS, et al. (2005) Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437: 764-769. (Pubitemid 41486548)
30. Beasley DW, Barrett AD (2002) Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol 76: 13097-13100.
31. Lok SM, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, et al. (2008) Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol 15: 312-317.
32. Mukhopadhyay S, Kuhn RJ, Rossmann MG (2005) A structural perspective of the flavivirus life cycle. 3: 13-22.
33. Volk DE, Beasley DW, Kallick DA, Holbrook MR, Barrett AD, et al. (2004) Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J Biol Chem 279: 38755-38761.
34. Volk DE, Lee YC, Li X, Thiviyanathan V, Gromowski GD, et al. (2007) Solution structure of the envelope protein domain III of dengue-4 virus. Virology 364: 147-154. (Pubitemid 46829273)
35. Yu S, Wuu A, Basu R, Holbrook MR, Barrett AD, et al. (2004) Solution structure and structural dynamics of envelope protein domain III of mosquito-and tick-borne flaviviruses. Biochemistry 43: 9168-9176. (Pubitemid 38924450)
36. Wahala WM, Kraus AA, Haymore LB, Accavitti-Loper MA, de Silva AM (2009) Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 392: 103-113.
37. Babu JP, Pattnaik P, Gupta N, Shrivastava A, Khan M, et al. (2008) Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice. Vaccine 26: 4655-4663.
38. Bernardo L, Hermida L, Martin J, Alvarez M, Prado I, et al. (2008) Anamnestic antibody response after viral challenge in monkeys immunized with dengue 2 recombinant fusion proteins. Arch Virol 153: 849-854.